March 27, 2020
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Case Number:
1:20-md-02930
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Abrams & Bayliss
- Duane Morris
- Heyman Enerio
- Kratz & Barry
- McCarter & English
- Morris James
- Parker Poe
- Perkins Coie
- Phillips McLaughlin
- Pinckney Weidinger
- Potter Anderson
- Richards Layton
- Schrader Companion
- Shaw Keller
- Smith Katzenstein
- Stamoulis & Weinblatt
- Steptoe & Johnson PLLC
- Venable LLP
- Young Conaway
Companies
- Alembic
- Alembic Pharmaceuticals Ltd.
- Alkem Laboratories Ltd.
- Aurobindo Pharma Ltd.
- Biocon Ltd.
- Dr. Reddy's Laboratories Ltd.
- Hetero Labs Ltd.
- Laurus Labs Pvt Ltd.
- Lupin Ltd.
- Macleods Pharmaceuticals Ltd.
- Teva Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Viatris Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 11, 2025
MSN Beats Novartis' Patent Suit Over Entresto
A Delaware federal judge on Friday found that Novartis couldn't show that MSN Pharmaceuticals Inc. infringed a patent related to its blockbuster drug Entresto, the latest in the company's wide-ranging fight to keep a generic version of the product off the market.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login